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Abstract
Background: Epidemiological investigation of insulin resistance is difficult. Standard measures of insulin resistance
require invasive investigations, which are impractical for large-scale studies. Surrogate measures using fasting blood
samples have been developed, but even these are difficult to obtain in population-based studies. Measures of
insulin resistance have not been validated in non-fasting blood samples. Our objective was to assess the
correlations between fasting and non-fasting measures of insulin resistance/sensitivity.
Methods: Fasting and non-fasting measurements of metabolic function were compared in 30 volunteers (15 male)
aged 28 to 48 years. Participants provided a morning blood sample after an overnight fast and a second sample
approximately 4 hours after lunch on the same day.
Results: Non-fasting levels of the adipokines leptin, adiponectin, and leptin:adiponectin ratios were not significantly
different and highly correlated with fasting values (r values 0.95, 0.96, and 0.95 respectively, P values < 0.001). There
were moderate correlations between fasting and non-fasting estimates of insulin sensitivity using the McAuley (r =
0.60, P = 0.001) and QUICKI formulae (r = 0.39, P = 0.037). The HOMA-IR estimate of insulin resistance was also
moderately correlated (r = 0.45, P = 0.016).
Conclusions: Semi-fasting measures of leptin, adiponectin, and leptin:adiponectin ratios correlate closely with
fasting values and are likely to be sufficient for population-based research. Other measures of insulin resistance or
sensitivity in semi-fasted blood samples are moderately correlated with values obtained after an overnight fast.
These estimates of insulin resistance/sensitivity may also be adequate for many epidemiological studies and would
avoid the difficulties of obtaining fasting blood samples.
Background
Assessment of insulin resistance presents a challenge for
epidemiological research. The standard method to mea-
sure insulin resistance/sensitivity is the euglcaemic clamp
technique, which requires infusions of insulin and glucose
over about 2 hours with measurements of blood glucose
every few minutes. The test is unsuitable for large-scale
population-based studies because it is invasive, expensive,
and time-consuming [1]. Hence a number of surrogate
measures have been developed based on insulin, glucose
and triglyceride levels in fasting blood [1,2]. Many of these
surrogates correlate strongly with direct measurements
of insulin resistance and are generally regarded as valid
measures [3].
Even fasting blood tests can be problematic for popula-
tion-based studies, however, because many participants
may be unwilling to fast overnight before attending the
study: for example, less than half of the participants
followed the instruction to fast in the National Health and
Nutrition Examination Survey [4]. Moreover, some partici-
pants may not admit to having eaten on the morning of
the test increasing measurement variability due to the mix
of fasting and non-fasting samples and introducing the
potential for bias. Fasting also restricts scheduling of
assessments because the blood tests are usually taken
before breakfast and adds to the time and resources needed
for the research because participants may need to be pro-
vided with food before undergoing further assessments.
Levels of adiponectin, and the ratio between leptin and
adiponectin have also been proposed as surrogate mar-
kers of insulin resistance [5,6]. It has been suggested that
the leptin:adiponectin ratio may be a stable indicator in
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modest [6-8]. Nevertheless, both are altered by prolonged
fasting and studies reporting non-fasting measures of
these adipokines have been criticised because of this [9].
It is unknown whether insulin resistance can be assessed
using non-fasting blood. For most epidemiological
purposes, the issue is not whether there are differences in
the absolute values between fasting and non-fasting mea-
sures, but the extent to which non-fasting values reflect
the underlying trait. We hypothesised that fasting and
non-fasting metabolic indices would be highly correlated
and, in preparation for an assessment of the 38 year-old
participants of the Dunedin Multidisciplinary Health &
Development Study,[10] sought to compare these in
healthy adults.
Methods
Volunteers aged 28-48 years were recruited. Pregnant
women, people with diabetes, and those on medication
likely to affect glucose or fat metabolism (e.g. oral corti-
costeroids) were excluded. Participants reported their
height and weight.
Participants were instructed not to eat or drink anything
other than water after midnight before the assessment day.
They were asked to attend the laboratory for a blood test
between 8 and 9 am. They were then provided with break-
fast at a nearby restaurant. They were asked to eat lunch
between 12 noon and 12.30pm on the same day and
return for a second blood test between 4 and 4.30 that
afternoon: approximately 4 hours after lunch. Drinks were
permitted during the afternoon, but participants were
asked to avoid drinks containing sugar and food. Partici-
pants were asked when they had last eaten when they
attended for each blood test. No restrictions were placed
on the participants’ physical activity during the assessment
day. To obtain an indication of the short-term repeatabil-
ity of the tests, 10 participants also provided a second fast-
ing morning blood sample, 1 week to 2 months later.
Blood samples were obtained while seated and were ana-
lysed for glucose and triglycerides on a Roche Modular
analyser (Roche Diagnostics, Mannheim, Germany) using
enzymatic assays. Plasma leptin was measured by radioim-
munoassay (HL81K, Linco Research, St. Charles MO,
USA: coefficient of variation 7%). Adiponectin was mea-
sured by enzyme-linked immunosorbent assay (ARCP30,
Millipore, St. Charles MO, USA: coefficient of variation
less than 8.4%) Samples for insulin were placed on ice
immediately after being drawn. Plasma free insulin was
measured on a Roche Elecsys 2010 analyser (Roche Diag-
nostics: coefficient of variation 3.8%) after polyethylyene
glycol precipitation of interfering antibodies.
Estimates of insulin sensitivity were calculated using the
McAuley formula (exp(2.63-0.28 × ln(insulin) - 0.31 × ln
(triglyceride)),[2]. and Quantitative Insulin Sensitivity
Check Index (QUICKI: 1/(ln(insulin)+ln(glucose)) [11].
The Homeostasis Model Assessment of Insulin Resistance
(HOMA-IR) was determined from glucose and insulin
values using the online calculator [12,13]. Leptin, adipo-
nectin, insulin, HOMA-IR, and leptin:adiponectin ratio
values were log-transformed to approximate normal distri-
butions. The primary outcome of this analysis was the sex-
adjusted partial correlation coefficient between the fasting
and non-fasting values. Fasting and non-fasting values
were also compared using paired t-tests.
A sample size of 30 was calculated to provide sufficient
power to detect significant correlations between samples
of r = 0.3 or greater. Correlations smaller than this would
be unlikely to be of interest to epidemiological researchers
wishing to find a surrogate measure for fasting values. The
study was approved by the University ethics committee.
All participants provided written informed consent.
Results
15 men and 15 women aged 28 to 48 years (mean 39.6)
were recruited. The mean self-reported Body Mass Index
was 25.3 kg/m
2 (range 20 to 32). Fasting times for the
morning blood test were between 9 hours 25 minutes and
14 hours 43 minutes (mean 12:24). Time since last food
before the afternoon bloodt e s tv a r i e df r o m2h o u r s
30 minutes to 5 hours 55 minutes (mean 3:55). 5 partici-
pants had eaten within 3 hours 30 minutes of this test.
Triglycerides were higher in non-fasting samples and
there was a trend to higher insulin levels. Glucose, leptin,
and adiponectin were not significantly different. Mean
levels and sex-adjusted correlation coefficients between
fasting and non-fasting values are shown in table 1.
Calculated insulin sensitivity using the McAuley formula
was lower for the afternoon non-fasting blood sample, but
highly correlated with the fasting measure (Table 1). Fast-
ing and non-fasting values for QUICKI and HOMA-IR
were moderately correlated. Leptin:adiponectin ratios were
similar in fasting and non-fasting samples and were very
highly correlated.
Discussion
This study demonstrates strong and significant correla-
tions between fasting and non-fasting blood tests for sev-
eral metabolic indicators. These findings suggest that it
may be acceptable to use non-fasting bloods to assess
insulin resistance in epidemiological studies. This would
avoid a number of difficulties inherent in asking partici-
pants to fast overnight and may remove one of the barriers
to participation in these studies.
The adipokine measurements were the most stable
measures between fasting and non-fasting samples. Non-
fasting levels of leptin, adiponectin, and the leptin:adipo-
nectin ratio were not significantly different and were very
strongly correlated with the fasting values. Hence, we can
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Although adipokines levels have previously been shown
to be influenced by fasting, this appears to require pro-
longed food deprivation [14].
As expected, triglycerides were higher in non-fasting
samples. Despite this, there was a strong correlation
between the fasting and non-fasting values. More impor-
tantly, estimates of insulin sensitivity derived from non-
fasting insulin and triglyceride levels using the McAuley
formula were moderately strongly correlated with fasting
estimates (r = 0.6). Correlations of this magnitude may
be adequate for many epidemiological purposes.
We did not compare non-fasting measures of insulin
resistance with the so-called “gold-standard” technique:
the euglycaemic clamp [1]. A fasting measure of insulin
resistance using the McAuley formulae correlates moder-
ately well with this measure and it is plausible that a
non-fasting version of this formula would not correlate
as well [2,3]. However, all methods of assessing insulin
resistance have limitations and problems with repeatabil-
ity [1]. In fact the correlation between same-day fasting
and non-fasting samples for the McAuley formula was
similar to the correlation between two fasting samples
measured 1 week to 8 weeks apart in 10 participants who
provided a second fasting sample, suggesting that non-
fasting estimates may be no worse than the short-term
repeatability of the fasting estimate. Other estimates of
insulin sensitivity or resistance (QUICKI and HOMA-IR,
both of which are based on insulin and glucose measure-
ments) were also moderately correlated between fasting
and non-fasting samples.
It should be noted that the finding that fasting and
non-fasting measures were correlated does not mean that
the measures are equivalent: there were differences in the
mean values of some of the measurements despite the
correlations between them. We also do not know if a
change in the value of one of these measurements over
time will necessarily be accompanied by an equivalent
change in the other and it remains possible that they
reflect different aspects of the underlying metabolic trait.
However, these considerations apply to all surrogate mar-
kers of insulin resistance whether they are fasting or not
[15].
A number of methodological issues deserve comment.
This study was part of the preparation for an assessment
of 38 year-olds [10]. Hence the age range was restricted to
age 38 +/-10 years to avoid false inflation of the correla-
tions between fasting and non-fasting samples due to age-
related differences (adjusting the correlation coefficients
for age made no material difference to the findings). We
purposefully made no attempt to influence the content or
quantity of the mid-day meal prior to the non-fasting
blood test. It is difficult to standardise meals in popula-
tion-based studies because of differences in food prefer-
ences and appetite. Therefore we decided to let the
participants chose their own lunch to make a realistic
assessment of the variability between fasting and non-
fasting values. We also permitted non-sugary drinks
(including tea and coffee with milk), but not food, in the
four hours before the afternoon non-fasting test. We
believe that this is what might reasonably be achieved in a
population-based study. Our findings may have been dif-
ferent if the participants had been permitted to eat during
this time. In fact, despite being asked to avoid food for
approximately 4 hours before the afternoon blood test,
5 participants had consumed food less than 3 hours 30
minutes before. Omitting these participants from the ana-
lysis improved the correlations between fasting and non-
fasting values for triglycerides (r = 0.80), insulin (r = 0.45),
McAuley (r = 0.76), HOMA-IR (r = 0.62), and QUICKI
(r = 0.56). This observation suggests that the 4-hour fast is
important, although more data are needed to confirm this.
Achieving a 4-hour semi-fasting state is likely to be much
easier for researchers and more acceptable to participants
than an 8 - 10 hour overnight fast. This does not require
participants to miss breakfast, and most people are
Table 1 Mean Fasting and Non-Fasting Values and Correlation Coefficients
Comparison of means
a Sex-adjusted partial correlation
Fasting Non-Fasting
Variable Mean 95% CI Mean 95% CI P r P
Glucose mmol/L 5.06 4.88, 5.24 4.98 4.80, 5.16 0.44 0.40 0.033
Insulin
b pmol/L 31.8 25.4, 39.9 40.8 29.1, 57.3 0.11 0.44 0.016
Triglyceride mmol/L 0.89 0.74, 1.04 1.52 1.22, 1.81 < 0.001 0.65 < 0.001
Leptin
b μg/L 5.81 4.09, 8.24 6.00 4.33, 8.3 0.37 0.95 < 0.001
Adiponectin
b μg/L 7.25 5.88, 8.93 6.45 4.51, 9.23 0.17 0.96 < 0.001
McAuley 10.0 9.1, 10.9 8.3 7.1, 9.6 0.002 0.60 0.001
QUICKI 0.17 0.16, 0.17 0.16 0.15, 0.17 0.41 0.39 0.037
HOMA-IR
b 0.60 0.48, 0.75 0.76 0.54, 1.07 0.12 0.44 0.016
Leptin:adiponectin ratio
b 0.83 0.60, 1.15 0.83 0.61, 1.13 0.89 0.95 < 0.001
a P values from two-sided paired t-tests.
b Values log-transformed before analyses: geometric means are presented.
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many research protocols take more than 4 hours to com-
plete, permitting the researchers to monitor whether the
participants have observed the request to avoid eating dur-
ing this time.
Conclusions
There are strong correlations between estimates of insulin
resistance and sensitivity in fasting and non-fasting blood
samples. Leptin, adiponectin and the leptin:adiponectin
ratio did not differ and were strongly correlated between
fasting and non fasting samples. The findings suggest that
fasting samples are not required for measurement of adi-
pokines and that standardised semi-fasting blood tests to
estimate insulin resistance may be adequate for many epi-
demiological purposes.
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